Virginia Retirement Systems Et Al Concert Pharmaceuticals, Inc. Transaction History

Virginia Retirement Systems Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 26, 2019	SELL	$9.44 - $13.12 $681,568 - $947,264	-72,200 Closed	0 $0
Q1 2019 Apr 25, 2019	SELL	$12.07 - $17.54 $25,347 - $36,834	-2,100 Reduced 2.83%	72,200 $871,000
Q4 2018 Feb 07, 2019	BUY	$11.25 - $16.17 $546,750 - $785,862	48,600 Added 189.11%	74,300 $932,000
Q3 2018 Nov 02, 2018	BUY	$12.82 - $17.88 $12,820 - $17,880	1,000 Added 4.05%	25,700 $381,000
Q2 2018 Aug 03, 2018	BUY	$16.83 - $21.66 $415,700 - $535,002	24,700 New	24,700 $416,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.